Deanna L. Pratt

Array ( [id] => 13051939 [patent_doc_number] => 10047354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-14 [patent_title] => Reduction of dimer content in factor VII polypeptide compositions by heat treatment [patent_app_type] => utility [patent_app_number] => 12/675004 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6721 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12675004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6135116 [patent_doc_number] => 20110008851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Carboxylic Acid Producing Member of the Pasteurellaceae' [patent_app_type] => utility [patent_app_number] => 12/673714 [patent_app_country] => US [patent_app_date] => 2008-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17262 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008851.pdf [firstpage_image] =>[orig_patent_app_number] => 12673714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5507981 [patent_doc_number] => 20090081188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'GLYCOPEGYLATED FACTOR IX' [patent_app_type] => utility [patent_app_number] => 12/184956 [patent_app_country] => US [patent_app_date] => 2008-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 31195 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081188.pdf [firstpage_image] =>[orig_patent_app_number] => 12184956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6509757 [patent_doc_number] => 20100261167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'In vivo screen using chemical inducers of dimerization' [patent_app_type] => utility [patent_app_number] => 12/221180 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17206 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261167.pdf [firstpage_image] =>[orig_patent_app_number] => 12221180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453506 [patent_doc_number] => 20090069543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Factor IXa for the treatment of bleeding disorders' [patent_app_type] => utility [patent_app_number] => 12/221086 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4776 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069543.pdf [firstpage_image] =>[orig_patent_app_number] => 12221086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852533 [patent_doc_number] => 20080318276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Human Coagulation Factor VII Variants' [patent_app_type] => utility [patent_app_number] => 12/178280 [patent_app_country] => US [patent_app_date] => 2008-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11249 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318276.pdf [firstpage_image] =>[orig_patent_app_number] => 12178280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585938 [patent_doc_number] => 20090105140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Albumin Fusion Proteins' [patent_app_type] => utility [patent_app_number] => 12/171154 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 122747 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105140.pdf [firstpage_image] =>[orig_patent_app_number] => 12171154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778261 [patent_doc_number] => 20080286259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'USE OF ACTIVATED COAGULATION FACTOR VII FOR TREATING THROMBOLYTIC THERAPY-INDUCED MAJOR BLEEDINGS' [patent_app_type] => utility [patent_app_number] => 12/170916 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2220 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286259.pdf [firstpage_image] =>[orig_patent_app_number] => 12170916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321436 [patent_doc_number] => 20100196579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'PHOSPHATIDIC ACID PHOSPHATASE HOMOLOGS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/520634 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18602 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196579.pdf [firstpage_image] =>[orig_patent_app_number] => 12520634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059680 [patent_doc_number] => 08546115 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Esterases and their use' [patent_app_type] => utility [patent_app_number] => 12/668313 [patent_app_country] => US [patent_app_date] => 2008-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8204 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12668313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585459 [patent_doc_number] => 20090104661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Human Coagulation Factor VII Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/168632 [patent_app_country] => US [patent_app_date] => 2008-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17519 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104661.pdf [firstpage_image] =>[orig_patent_app_number] => 12168632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000640 [patent_doc_number] => 20110117072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'HYPERACTIVE VARIANTS OF THE TRANSPOSASE PROTEIN OF THE TRANSPOSON SYSTEM SLEEPING BEAUTY' [patent_app_type] => utility [patent_app_number] => 12/667527 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 21809 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117072.pdf [firstpage_image] =>[orig_patent_app_number] => 12667527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294232 [patent_doc_number] => 08222016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Recombinant C-terminal α-amidating enzyme derivative' [patent_app_type] => utility [patent_app_number] => 12/666032 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9077 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12666032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711088 [patent_doc_number] => 20080299614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Metabolically Engineered Bacterial Strains Having Non-Functional Endogenous Gluconate Transporters' [patent_app_type] => utility [patent_app_number] => 12/141522 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17184 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299614.pdf [firstpage_image] =>[orig_patent_app_number] => 12141522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272104 [patent_doc_number] => 20090075880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Albumin Fusion Proteins' [patent_app_type] => utility [patent_app_number] => 12/140228 [patent_app_country] => US [patent_app_date] => 2008-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 136200 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075880.pdf [firstpage_image] =>[orig_patent_app_number] => 12140228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6460444 [patent_doc_number] => 20100190238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'SYNTHESIS OF MYCOPHENOLIC ACID (MPA)' [patent_app_type] => utility [patent_app_number] => 12/663773 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11630 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190238.pdf [firstpage_image] =>[orig_patent_app_number] => 12663773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615282 [patent_doc_number] => 20100310546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'ACE2 Polypeptide' [patent_app_type] => utility [patent_app_number] => 12/664641 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 9192 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310546.pdf [firstpage_image] =>[orig_patent_app_number] => 12664641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6396758 [patent_doc_number] => 20100304461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Portable, Temperature and Chemically Inducible Expression Vector for High Cell Density Expression of Heterologous Genes in Escherichia Coli' [patent_app_type] => utility [patent_app_number] => 12/664118 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10302 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12664118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762372 [patent_doc_number] => 08114840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'Medicament containing activated antithrombin III' [patent_app_type] => utility [patent_app_number] => 12/137239 [patent_app_country] => US [patent_app_date] => 2008-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 53 [patent_no_of_words] => 14144 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114840.pdf [firstpage_image] =>[orig_patent_app_number] => 12137239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026337 [patent_doc_number] => 08535918 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Preparing method for (S)-3hydroxybutyric acid and (S)-3 hydroxybutyrate ester using recombinant microorganism' [patent_app_type] => utility [patent_app_number] => 12/733026 [patent_app_country] => US [patent_app_date] => 2008-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6083 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12733026 [rel_patent_id] =>[rel_patent_doc_number] =>)